secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2023-10-20T23:59:59+00:00
Accession:  0001683168-23-007302
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma amends warrants to $0.11 exercise price and removes CEO voting restriction
--------------------------------------------------------------------------------

- Reduces exercise price of outstanding Tradeable Warrants to $0.11; Pre-Funded Warrants to $0.001 per share.
- Removes provision that prohibited CEO Dr. Steve N. Slilaty from voting his Series B Preferred Stock.
- Amendment dated October 18, 2023 between Company and Equiniti Trust Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823007302/0001683168-23-007302-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823007302/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-007302

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer